Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Dec 20, 2024, 4:00 PM
4.990
+0.040 (0.81%)
After-hours: Dec 20, 2024, 5:47 PM EST

Sagimet Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-37.52-27.88-30.5-24.44-11.37-14.26
Depreciation & Amortization
-----0
Other Amortization
-----0.01
Loss (Gain) From Sale of Assets
-----0.02-
Loss (Gain) From Sale of Investments
-1.2-0.04-0.21---
Stock-Based Compensation
5.074.991.881.90.782.99
Other Operating Activities
0.140.140.130.880.120.07
Change in Accounts Payable
-1.030.122.920.56-0.361.28
Change in Other Net Operating Assets
-3.96-1.11.3-0.620.44-0.63
Operating Cash Flow
-38.49-23.77-24.49-21.71-10.42-10.55
Sale of Property, Plant & Equipment
----0.02-
Investment in Securities
-91.1512.58-32.01---
Other Investing Activities
------0.03
Investing Cash Flow
-91.1512.58-32.01-0.02-0.03
Long-Term Debt Repaid
------3.36
Net Debt Issued (Repaid)
------3.36
Issuance of Common Stock
109.3889.690.010.19--
Other Financing Activities
-4.56-3.52-0.09-1.25--
Financing Cash Flow
104.8286.17-0.079.7468.8918.49
Net Cash Flow
-24.8374.98-56.57-11.9758.497.91
Free Cash Flow
-38.49-23.77-24.49-21.71-10.42-10.55
Free Cash Flow Margin
--1188.30%----
Free Cash Flow Per Share
-1.32-2.27-132.65-177.11-107.87-
Cash Interest Paid
-----0.14
Levered Free Cash Flow
-28.21-15.08-13.21-14.27-5.96-
Unlevered Free Cash Flow
-28.21-15.08-13.21-14.27-5.96-
Change in Net Working Capital
4.70.86-4.321.35-0.39-
Source: S&P Capital IQ. Standard template. Financial Sources.